Please login to the form below

Not currently logged in
Email:
Password:

type 1 diabetes

This page shows the latest type 1 diabetes news and features for those working in and with pharma, biotech and healthcare.

Sanofi exits Zynquista alliance with Lexicon

Sanofi exits Zynquista alliance with Lexicon

The Sanofi/Lexicon partnered drug for type 1 diabetes was being co-developed as an add-on therapy to insulin injections to help improve blood sugar control. ... We believe that this potential, along with a European approval in type 1 diabetes, offer an

Latest news

  • Vertex eyes type 1 diabetes cure with biotech acquisition Vertex eyes type 1 diabetes cure with biotech acquisition

    Semma was founded to develop therapies for type 1 diabetes patients who depend on insulin injections. ... According to Vertex, the biotech is pioneering the use of stem cells as a potential cure for type 1 diabetes.

  • Tiziana joins type 1 diabetes prevention field Tiziana joins type 1 diabetes prevention field

    It is being evaluated in the treatment of a range of autoimmune diseases, including type 1 diabetes among others. ... Tiziana’s proprietary technology for the oral and nasal delivery of mAb’s in general, and foralumab specifically, have strong

  • Type 1 diabetes prevention promise sends Provention Bio soaring Type 1 diabetes prevention promise sends Provention Bio soaring

    031 significantly delayed the onset and diagnosis of Type 1 diabetes compared to placebo, by a median of 2 years in children and adults considered to be at high risk. ... Teplizumab is the first immune modulator to show a delay in the clinical onset of

  • Hansoh Pharma shares head skyward after HKEX debut Hansoh Pharma shares head skyward after HKEX debut

    Since its inception it has become a major producer of generic cancer and central nervous system drugs for China’s domestic market, and has also brought two Category 1.1 innovative ... drugs through to registration, including a once-weekly pegylated

  • Syncona launches another cell therapy company, Treg specialist Quell Syncona launches another cell therapy company, Treg specialist Quell

    such as type 1 diabetes, rheumatoid arthritis, inflammatory bowel disease, and graft-versus-host disease (GvHD). ... Still going it alone are companies like Caladrius Biosciences, with a cell-based Treg-based treatment called CLBS03 for type 1 diabetes

More from news
Approximately 10 fully matching, plus 130 partially matching documents found.

Latest Intelligence

  • The fight for affordable insulin The fight for affordable insulin

    After years of steeply rising prices, the issue has hit the national consciousness in the US, and people with type 1 diabetes and their families are taking direct action and coming ... T1International. Elizabeth Pfiester is the founder of T1International,

  • Quality in Care Diabetes 2018: the best in innovative diabetes care Quality in Care Diabetes 2018: the best in innovative diabetes care

    The most heartfelt category of the evening was undoubtedly The People’s Award, which was presented to Beth Baldwin, who lost her son at age 13 to undiagnosed type 1 diabetes ... type 1 diabetes.

  • No incentive for a cure No incentive for a cure

    The paradox of ‘cost-effective but unaffordable’ life-saving medicines. Type 1 diabetes, heart failure, HIV - all examples of diseases that have transitioned from fatal conditions to chronic diseases, thanks to

  • The rise of real-world evidence The rise of real-world evidence

    Diabeter, a Dutch chain of type 1 diabetes clinics bought by Medtronic in 2015, is an example of this trend. ... and then have it come through a pipe so it populates our practice management system,” Sue Willman, vice president of global diabetes

  • Taking a lean and careful approach Taking a lean and careful approach

    ulcerative colitis, type 1 diabetes and inflammatory bowel disease. ... This fits well with our mission to tackle unmet needs. Autoimmune conditions are increasing and diabetes is at epidemic levels.

More from intelligence
Approximately 2 fully matching, plus 19 partially matching documents found.

Latest appointments

  • JDRF names new CEO JDRF names new CEO

    Derek Rapp to lead diabetes research charity. The type 1 diabetes research charity JDRF has announced a change of leadership with the appointment of Derek Rapp as CEO. ... He now finds himself at the helm of the largest research organisation trying to

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Mixing up Focus Groups

    Let’s consider a person with Type 1 diabetes, for a moment. ... Wouldn’t that provide a rich, true and insightful understanding of the real world where diabetes is concerned?

  • World Diabetes Day: Interaction and impact of diabetes on mental health

    Including a case study showing the perspective of a young person newly diagnosed with type 1 diabetes. ... and Turner, H.M., 2005. The relationship of disordered eating habits and attitudes to clinical outcomes in young adult females with type 1 diabetes.

  • Attigo (part of the Mednet Group)

    For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. ... Including a case study showing the perspective of a young person newly

  • Getting personal with wearable tech

    In partnership with Diabetes UK and Hewlett Packard it is deploying mobile health self-management tools (wearable sensors and software) for people with Type 1 and Type 2 diabetes to

  • How technology is shaping patient education

    The relative simplicity of producing an app has been demonstrated by a recent study by Bournemouth University showing how people with type 1 diabetes can participate effectively in the design of ... 10] Pulman, A., Hill, J. and Masding, M. G., 2013. The

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics